Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Angelousi

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Neuroendocrinology|October 10, 2019
Authors' Response to the Letter by Lamarca et al. Entitled "Temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration" Regarding "Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms"Eleftherios Chatzellis, Kosmas Daskalakis, Anna Angelousi, et al.
Journal of Neuroendocrinology|April 27, 2023
Pancreatic metastases in patients with neuroendocrine neoplasms: A multi-centre cohort studyMarina Tsoli, Kosmas Daskalakis, Maria Wedin, et al.
Neuroendocrinology|June 6, 2019
Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine NeoplasmsEleftherios Chatzellis, Anna Angelousi, Kosmas Daskalakis, et al.
European Thyroid Journal|August 6, 2016
Familiar Papillary Thyroid Carcinoma in a Large Brazilian Family Is Not Associated with Succinate Dehydrogenase DefectsElen Dias Accordi, Paraskevi Xekouki, Bruna Azevedo, et al.
Journal of Personalized Medicine|February 25, 2023
The Role of Somatostatin Analogues in the Control of Diarrhea and Flushing as Markers of Carcinoid Syndrome: A Systematic Review and Meta-AnalysisKrystallenia I Alexandraki, Anna Angelousi, Eleftherios Chatzellis, et al.
Endocrine|March 10, 2020
Expression of clock-related genes in benign and malignant adrenal tumorsAnna Angelousi, Narjes Nasiri-Ansari, Angeliki Karapanagioti, et al.
Cancers|February 9, 2020
Effects of Germline CYP2W1*6 and CYP2B6*6 Single Nucleotide Polymorphisms on Mitotane Treatment in Adrenocortical Carcinoma: A Multicenter ENSAT StudyBarbara Altieri, Silviu Sbiera, Sabine Herterich, et al.
Endocrine-Related Cancer|August 14, 2023
Embryonic stem cell factor FOXD3 (Genesis) defects in gastrointestinal stromal tumorsFabio R Faucz, Anelia D Horvath, Guillaume Assié, et al.
The Journal of Clinical Endocrinology and Metabolism|May 16, 2017
Somatic USP8 Gene Mutations Are a Common Cause of Pediatric Cushing DiseaseFabio R Faucz, Amit Tirosh, Christina Tatsi, et al.
Endocrine|July 31, 2025
Metabolic phenotype in non-aldosterone producing adrenal adenomas with co-existent polycystic ovary syndrome: a joint Ens@t projectAriadni Spyroglou, Panagiota Konstantakou, Marianna Minnetti, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Neuroendocrinology|October 10, 2019
Authors' Response to the Letter by Lamarca et al. Entitled "Temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration" Regarding "Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms"Eleftherios Chatzellis, Kosmas Daskalakis, Anna Angelousi, et al.
Journal of Neuroendocrinology|April 27, 2023
Pancreatic metastases in patients with neuroendocrine neoplasms: A multi-centre cohort studyMarina Tsoli, Kosmas Daskalakis, Maria Wedin, et al.
Neuroendocrinology|June 6, 2019
Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine NeoplasmsEleftherios Chatzellis, Anna Angelousi, Kosmas Daskalakis, et al.
European Thyroid Journal|August 6, 2016
Familiar Papillary Thyroid Carcinoma in a Large Brazilian Family Is Not Associated with Succinate Dehydrogenase DefectsElen Dias Accordi, Paraskevi Xekouki, Bruna Azevedo, et al.
Journal of Personalized Medicine|February 25, 2023
The Role of Somatostatin Analogues in the Control of Diarrhea and Flushing as Markers of Carcinoid Syndrome: A Systematic Review and Meta-AnalysisKrystallenia I Alexandraki, Anna Angelousi, Eleftherios Chatzellis, et al.
Endocrine|March 10, 2020
Expression of clock-related genes in benign and malignant adrenal tumorsAnna Angelousi, Narjes Nasiri-Ansari, Angeliki Karapanagioti, et al.
Cancers|February 9, 2020
Effects of Germline CYP2W1*6 and CYP2B6*6 Single Nucleotide Polymorphisms on Mitotane Treatment in Adrenocortical Carcinoma: A Multicenter ENSAT StudyBarbara Altieri, Silviu Sbiera, Sabine Herterich, et al.
Endocrine-Related Cancer|August 14, 2023
Embryonic stem cell factor FOXD3 (Genesis) defects in gastrointestinal stromal tumorsFabio R Faucz, Anelia D Horvath, Guillaume Assié, et al.
The Journal of Clinical Endocrinology and Metabolism|May 16, 2017
Somatic USP8 Gene Mutations Are a Common Cause of Pediatric Cushing DiseaseFabio R Faucz, Amit Tirosh, Christina Tatsi, et al.
Endocrine|July 31, 2025
Metabolic phenotype in non-aldosterone producing adrenal adenomas with co-existent polycystic ovary syndrome: a joint Ens@t projectAriadni Spyroglou, Panagiota Konstantakou, Marianna Minnetti, et al.
Pageof 10